Marketing-authorisation holder · United States
Orca Biosystems Inc.
1 medicine in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
1 medicine
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| tregzi>=1.0 10^6hspc cells,0.9-3.510^6 treg cells,0.9-6.910^6 tcon cells /patient kg · Solution | Allogeneic regulatory t cell immunotherapy with hspc, T cells | United States | Marketed | 2026 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 1 | 1 | 0 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.